Pulmonx Corp (LUNG) — 10-Q Filings

10-Q Filings (5)

• Pulmonx Q2 Revenue Up 21%, But Net Loss Widens to $25.3M — Aug 1, 2025 Risk: high
  Pulmonx Corp reported a net loss of $25.3 million for the three months ended June 30, 2025, a significant increase from the $20.1 million net loss in the prior-
• Pulmonx Corp Files Q1 2025 10-Q — May 2, 2025 Risk: low
  Pulmonx Corp filed its 10-Q for the period ending March 31, 2025. The filing details financial information for the first quarter of 2025, including changes in c
• Pulmonx Corp. Files Q3 2024 10-Q — Nov 1, 2024 Risk: medium
  Pulmonx Corp. filed its 10-Q for the period ending September 30, 2024. The filing details financial performance and operational updates for the company, which i
• Pulmonx Corp Files 10-Q for Q2 2024 — Aug 2, 2024 Risk: medium
  Pulmonx Corp filed its 10-Q for the period ending June 30, 2024. The filing details the company's financial performance and operations. Key financial data and o
• Pulmonx Corp Files 10-Q for Period Ending March 31, 2024 — May 3, 2024 Risk: low
  Pulmonx Corp (LUNG) filed a Quarterly Report (10-Q) with the SEC on May 3, 2024. Pulmonx Corp filed its quarterly report (10-Q) for the period ending March 31,

Popular Companies

AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX